Regulation by survivin of cancer cell death induced by F14512, a polyamine-containing inhibitor of DNA topoisomerase II

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Apoptosis

• Publication date

  2011-11-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10495-011-0681-2PMID 22127645
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An Integrated Drosophila Model System Reveals Unique Properties for F14512, a Novel Polyamine-Containing Anticancer Drug That Targets Topoisomerase II

  2011cited by this paper
• Preclinical activity of F14512, designed to target tumors expressing an active polyamine transport system

  2011cited by this paper
• Survivin and escaping in therapy‐induced cellular senescence

  2011cited by this paper
• Interactions between the etoposide derivative F14512 and human type II topoisomerases: implications for the C4 spermine moiety in promoting enzyme-mediated DNA cleavage.

  2011cited by this paper
• Recent advances in anti-survivin treatments for cancer.

  2010cited by this paper
• A fluorescent biomarker of the polyamine transport system to select patients with AML for F14512 treatment.

  2010cited by this paper
• Inhibition of mitochondrial respiration mediates apoptosis induced by the anti-tumoral alkaloid lamellarin D

  2010cited by this paper
• Antitumor conjugates with polyamine vectors and their molecular mechanisms

  2010cited by this paper
• Therapy-induced senescence in cancer.

  2010cited by this paper
• Protocols to detect senescence-associated beta-galactosidase (SA-βgal) activity, a biomarker of senescent cells in culture and in vivo

  2009cited by this paper
• Essential role of mitochondria in apoptosis of cancer cells induced by the marine alkaloid Lamellarin D

  2009cited by this paper
• Targeting DNA topoisomerase II in cancer chemotherapy

  2009cited by this paper
• Apoptosis-related mitochondrial dysfunction defines human monocyte-derived dendritic cells with impaired immuno-stimulatory capacities

  2008cited by this paper
• Survivin, cancer networks and pathway-directed drug discovery

  2008cited by this paper
• F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system.

  2008cited by this paper
• Overcoming chemoresistance of non-small cell lung carcinoma through restoration of an AIF-dependent apoptotic pathway

  2008cited by this paper
• Cellular response to etoposide treatment.

  2007cited by this paper
• Characterization of highly frequent epitope-specific CD45RA+/CCR7+/- T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A*0201+ BKV-seropositive donors

  2006cited by this paper
• Etoposide (VP-16) elicits apoptosis following prolonged G2-M cell arrest in p53-mutated human non-small cell lung cancer cells.

  2005cited by this paper
• Role of O6-alkylguanine-DNA alkyltransferase in the cytotoxic activity of cloretazine

  2005cited by this paper
• Apoptosis-inducing factor determines the chemoresistance of non-small-cell lung carcinomas

  2004cited by this paper
• Caspase inhibition switches doxorubicin-induced apoptosis to senescence

  2003cited by this paper
• Daunorubicin-induced variations in gene transcription: commitment to proliferation arrest, senescence and apoptosis.

  2003cited by this paper
• Apoptosis induced by topoisomerase inhibitors.

  2003cited by this paper
• A p34(cdc2) survival checkpoint in cancer.

  2002cited by this paper
• Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction*

  2002cited by this paper
• Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent

  2001cited by this paper
• Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells.

  2000cited by this paper
• Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin.

  2000cited by this paper
• A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents.

  1999cited by this paper
• A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

  1995cited by this paper
• Programmed cell death and extrathymic reduction of Vβ8+CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B

  1991cited by this paper

• The survival and proliferation of osteosarcoma cells are dependent on the mitochondrial BIG3‐PHB2 complex formation

  2021cites this paper
• Randomized, double-blind trial of F14512, a polyamine-vectorized anticancer drug, compared with etoposide phosphate, in dogs with naturally occurring lymphoma

  2020cites this paper
• The lead optimization of the polyamine conjugate of flavonoid with a naphthalene motif: Synthesis and biological evaluation.

  2018cites this paper
• Discovery of the Polyamine Conjugate with Benzo[ cd]indol-2(1 H)-one as a Lysosome-Targeted Antimetastatic Agent.

  2018cites this paper
• Phase I dose-escalation study of F14512, a polyamine-vectorized topoisomerase II inhibitor, in patients with platinum-refractory or resistant ovarian cancer

  2018cites this paper
• Synthesis and Biological Evaluation of Novel Aromatic Imide-Polyamine Conjugates

  2016cites this paper
• F14512, a polyamine-vectorized inhibitor of topoisomerase II, exhibits a marked anti-tumor activity in ovarian cancer.

  2016cites this paper
• Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitors.

  2016cites this paper
• A New Generation of Cell-Targeted Drugs for Cancer Treatment

  2014cites this paper
• Another Facet to the Anticancer Response to Lamellarin D: Induction of Cellular Senescence through Inhibition of Topoisomerase I and Intracellular Ros Production

  2014cites this paper
• The antitumor drug F14512 enhances cisplatin and ionizing radiation effects in head and neck squamous carcinoma cell lines.

  2014cites this paper
• Activity of the polyamine-vectorized anti-cancer drug F14512 against pediatric glioma and neuroblastoma cell lines.

  2014cites this paper
• Evaluation de combinaisons thérapeutiques ciblées en cancérologie des voies aérodigestives supérieures. Mise au point d’un modèle tumoral in vivo

  2014cites this paper
• Cell-targeted cytotoxics: a new generation of cytotoxic agents for cancer treatment

  2014cites this paper
• Etude des mécanismes d'action de nouvelles molécules utilisées seules ou en association avec les radiations ionisantes dans les cancers pédiatriques

  2013cites this paper
• F14512, a polyamine-vectorized anti-cancer drug, currently in clinical trials exhibits a marked preclinical anti-leukemic activity

  2013cites this paper
• Accelerated cellular senescence in solid tumor therapy.

  2012cites this paper